Zydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditions
Fluocinonide cream USP, 0.1 per cent, approved by USFDA is indicated to treat a variety of skin conditions such as psoriasis, eczema, dermatitis, allergies and rash, Zydus Cadila said.
New Delhi: Drug firm Zydus Cadila on Tuesday said it has received approval from the US health regulator to market generic Fluocinonide cream used for the treatment of various skin conditions. The final approval from the United States Food and Drug Administration (USFDA) is to market Fluocinonide cream USP, 0.1 per cent, Zydus Cadila said in a statement.
The drug will be manufactured at the group's topical manufacturing facility at Ahmedabad, it added.
It is used to treat a variety of skin conditions such as psoriasis, eczema, dermatitis, allergies and rash, Zydus Cadila said.
The group now has 279 approvals and has so far filed over 386 abbreviated new drug applications (ANDAs) since the commencement of its filing process, it added.
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd